Crescita Therapeutics (CRRTF, $0.02) was a top loser over the last three months, falling -9 to $0.02 per share. A.I.dvisor analyzed 252 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending August 15, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.